CIP
PCRX icon

Cornerstone Investment Partners’s Pacira BioSciences PCRX Stock Holding History

Cornerstone Investment Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,525
Closed -$247K – 315
2021
Q1 		$247K Hold
3,525
– – 0.01% 185
2020
Q4 		$211K Hold
3,525
– – 0.01% 159
2020
Q3 		$212K Buy
+3,525
New +$205K 0.01% 115

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Cornerstone Investment Partners's PCRX Position: Q2 2021 in Review

Cornerstone Investment Partners sold out of Pacira BioSciences (PCRX) in Q2 2021, closing a stake of 3,525 shares — an estimated $247K sold.

Cornerstone Investment Partners first reported a position in PCRX in Q3 2020 and held it in 3 quarters. The position peaked at $247K in Q1 2021. 262 funds tracked by Wall St. Rank hold PCRX as of Q2 2021.

  • Cornerstone Investment Partners reported no remaining Pacira BioSciences position as of Q2 2021 after selling out during the quarter.
  • Cornerstone Investment Partners sold 3,525 Pacira BioSciences shares in Q2 2021, an estimated $247K.
  • Cornerstone Investment Partners first reported a position in Pacira BioSciences in Q3 2020 and held it in 3 quarters.
  • Cornerstone Investment Partners's Pacira BioSciences position peaked at $247K in Q1 2021.
  • 262 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2021.

Based on Cornerstone Investment Partners's 13F filing for Q2 2021, filed 29 Jul 2021.